RxDoctor Payments Data

Matthew Wang

Corneal and Contact Management · Irvine, CANPI 1043210578

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,971 of the $3,162 with a category attached, or 62.3%. 14 manufacturers reported payments, led by Alcon at 53.2% of the total. Reporting peaked in 2019 at $1,747 and has fallen 69.5% since, to $532 in 2025.

$3,162in general payments, 2019–2025

Across 37 payments — averaging $85.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Glaukos Corporation$281
  • Sight Sciences, Inc.$148
  • NEW World Medical,inc.$147
  • Johnson & Johnson Vision Care, Inc.$147
  • Coopervision Inc.$125
  • plus $629 from 8 others
$92,305in research payments, 2019–2025

Across 27 payments — averaging $3418.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$70K
  • Alcon Research LLC$22K

What the payments were for

  • Travel & lodging$1,04933%
  • Food & beverage$1,97162%
  • Gifts$391%
  • Entertainment$1033%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,162 in reported general payments places this provider in the 70th percentile of 140 corneal and contact management providers in California.

See all corneal and contact management providers in California

Medicare billing

Part B allowed, 2024
$15,376
Medicare patients
103
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other corneal and contact management in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →